Cannabinoid Receptor Type-2 in B Cells Is Associated with Tumor Immunity in Melanoma

Cannabinoid Receptor Type-2 in B Cells Is Associated with Tumor Immunity in Melanoma

Agents targeting the endocannabinoid system (ECS) have gained attention as potential cancer treatments. Given recent evidence that cannabinoid receptor 2 (CB2R) regulates lymphocyte development and inflammation, we performed studies on CB2R in the immune response against melanoma. Analysis of The Ca...

Full description

Bibliographic Details
Main Authors: Thomas Gruber, Steve Robatel, Mirela Kremenovic, Lukas Bäriswyl, Jürg Gertsch, Mirjam Schenk
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Cancers
Subjects:
cannabinoid receptor type-2
CB2R
endocannabinoid system
regulatory B cells
melanoma
Online Access:https://www.mdpi.com/2072-6694/13/8/1934

Internet

https://www.mdpi.com/2072-6694/13/8/1934

Similar Items